| Phase III trial assessing bevacizumab in stages II and III carcinoma of the colon: results of NSABP protocol C-08 CJ Allegra, G Yothers, MJ O'Connell, S Sharif, NJ Petrelli, LH Colangelo, ... Journal of Clinical Oncology 29 (1), 11, 2011 | 725 | 2011 |
| Initial safety report of NSABP C-08: a randomized phase III study of modified FOLFOX6 with or without bevacizumab for the adjuvant treatment of patients with stage II or III … CJ Allegra, G Yothers, MJ O'Connell, S Sharif, LH Colangelo, SH Lopa, ... Journal of Clinical Oncology 27 (20), 3385, 2009 | 304 | 2009 |
| The impact of capecitabine and oxaliplatin in the preoperative multimodality treatment in patients with carcinoma of the rectum: NSABP R-04. MS Roh, GA Yothers, MJ O'connell, RW Beart, HC Pitot, AF Shields, ... Journal of Clinical Oncology 29 (15_suppl), 3503-3503, 2011 | 303 | 2011 |
| Bevacizumab in stage II-III colon cancer: 5-year update of the National Surgical Adjuvant Breast and Bowel Project C-08 trial CJ Allegra, G Yothers, MJ O'Connell, S Sharif, NJ Petrelli, SH Lopa, ... Journal of clinical oncology 31 (3), 359, 2013 | 235 | 2013 |
| Primary mFOLFOX6 plus bevacizumab without resection of the primary tumor for patients presenting with surgically unresectable metastatic colon cancer and an intact asymptomatic … LE McCahill, G Yothers, S Sharif, NJ Petrelli, LL Lai, N Bechar, ... Journal of clinical oncology 30 (26), 3223, 2012 | 178 | 2012 |
| Long-term survival results of surgery alone versus surgery plus 5-fluorouracil and leucovorin for stage II and stage III colon cancer: pooled analysis of NSABP C-01 through C … NW Wilkinson, G Yothers, S Lopa, JP Costantino, NJ Petrelli, N Wolmark Annals of surgical oncology 17, 959-966, 2010 | 144 | 2010 |
| FOLFOX and FLOX regimens for the adjuvant treatment of resected stage II and III colon cancer S Sharif, MJ O'Connell, G Yothers, S Lopa, N Wolmark Cancer investigation 26 (9), 956-963, 2008 | 93 | 2008 |
| Comparative effectiveness of sphincter-sparing surgery versus abdominoperineal resection in rectal cancer: patient-reported outcomes in National Surgical Adjuvant Breast and … MM Russell, PA Ganz, S Lopa, G Yothers, CY Ko, A Arora, JN Atkins, ... Annals of surgery 261 (1), 144-148, 2015 | 61 | 2015 |
| Increasing utilization of multiparametric magnetic resonance imaging in prostate cancer active surveillance MM Fam, JG Yabes, LC Macleod, J Bandari, RM Turner II, SH Lopa, ... Urology 130, 99-105, 2019 | 36 | 2019 |
| Palliative care use amongst patients with bladder cancer LA Hugar, SH Lopa, JG Yabes, JA Yu, RM Turner, MM Fam, LC MacLeod, ... BJU international 123 (6), 968-975, 2019 | 36 | 2019 |
| Neoadjuvant therapy for rectal cancer: Mature results from NSABP protocol R-04. CJ Allegra, G Yothers, MJ O'Connell, MS Roh, RW Beart, NJ Petrelli, ... Journal of clinical oncology 32 (3_suppl), 390-390, 2014 | 35 | 2014 |
| Early pregnancy blood pressure elevations and risk for maternal and neonatal morbidity EF Sutton, SC Rogan, S Lopa, D Sharbaugh, MF Muldoon, JM Catov Obstetrics & Gynecology 136 (1), 129-139, 2020 | 34 | 2020 |
| Neoadjuvant rectal cancer (RC) score to predict survival: Potential surrogate endpoint for early phase trials. G Yothers, TJ George, NJ Petrelli, MJ O'Connell, RW Beart, CJ Allegra, ... Journal of clinical oncology 32 (15_suppl), 3533-3533, 2014 | 33 | 2014 |
| Final results from NSABP protocol R-04: Neoadjuvant chemoradiation (RT) comparing continuous infusion (CIV) 5-FU with capecitabine (Cape) with or without oxaliplatin (Ox) in … CJ Allegra, G Yothers, MJ O'Connell, MS Roh, SH Lopa, NJ Petrelli, ... Journal of clinical oncology 32 (15_suppl), 3603-3603, 2014 | 28 | 2014 |
| The efficacy of oxaliplatin (Ox) when added to 5-fluorouracil/leucovorin (FU/L) in stage II colon cancer. GA Yothers, CJ Allegra, MJ O'Connell, TJ George, S Sharif, NJ Petrelli, ... Journal of Clinical Oncology 29 (15_suppl), 3507-3507, 2011 | 27 | 2011 |
| Trends and appropriateness of perioperative chemotherapy for muscle-invasive bladder cancer LC Macleod, JG Yabes, M Yu, MM Fam, NE Hale, RM Turner II, SH Lopa, ... Urologic Oncology: Seminars and Original Investigations 37 (7), 462-469, 2019 | 19 | 2019 |
| Association of functional status and treatment choice among older men with prostate cancer in the Medicare Advantage population BL Jacobs, SH Lopa, JG Yabes, JB Nelson, AE Barnato, HB Degenholtz Cancer 122 (20), 3199-3206, 2016 | 16 | 2016 |
| A phase II trial of 5-fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) chemotherapy plus bevacizumab (bev) for patients (pts) with unresectable stage IV colon cancer and a … LE McCahill, GA Yothers, S Sharif, NJ Petrelli, S Lopa, MJ O'Connell, ... Journal of Clinical Oncology 28 (15_suppl), 3527-3527, 2010 | 16 | 2010 |
| Same-day discharge after minimal invasive hysterectomy: applications for improved value of care M Qi, S Lopa, S Adambekov, JA Harris, S Mansuria, RP Edwards, ... European Journal of Obstetrics & Gynecology and Reproductive Biology 259 …, 2021 | 12 | 2021 |
| Comparison of neoadjuvant and adjuvant chemotherapy in muscle-invasive bladder cancer LC Macleod, MM Fam, JG Yabes, NE Hale, RM Turner II, SH Lopa, ... Clinical Genitourinary Cancer 18 (3), 201-209. e2, 2020 | 12 | 2020 |
